The natural occurrence of mutation in the RPE65 gene in dogs [46] and mice [47, 48] that mimics human LCA has made possible the development of gene therapy protocols for the successful treatment of these animals [49-56] as well as the application of these gene therapy protocols to the human disease. The gene discussed is RPE65; the disease is Leber congenital amaurosis.